Emergent starts phase 1 trial of Zika virus immune globulin therapeutic

Image: Emergent BioSolutions initiates phase 1 trial of Zika virus drug ZIKV-IG. Photo: courtesy of jk1991 / FreeDigitalPhotos.net.